Source fact
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
0000031791-26-000027
Health Care · RVTY
Revvity
Reported results, filing history, and direct access to the source documents.
LATEST QUARTERLY REPORT
10-Q · Period ended 2026-07-05
Filed 2026-08-11. Values below belong to this filing, not a rolling twelve-month estimate. Duration figures may cover a full year or year-to-date period.
Source fact
us-gaap:NetIncomeLoss
0000031791-26-000027
Source fact
us-gaap:Assets
0000031791-26-000027
Source fact
us-gaap:NetCashProvidedByUsedInOperatingActivities
0000031791-26-000027
LATEST ANNUAL REPORT
10-K · Period ended 2025-12-28
Filed 2026-02-24. Values below belong to this filing, not a rolling twelve-month estimate. Duration figures may cover a full year or year-to-date period.
Source fact
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
0000031791-26-000012
Source fact
us-gaap:NetIncomeLoss
0000031791-26-000012
Source fact
us-gaap:Assets
0000031791-26-000012
Source fact
us-gaap:NetCashProvidedByUsedInOperatingActivities
0000031791-26-000012
Disclosure timeline
Latest tracked 10-K, 10-Q, amendments, and earnings-related 8-K Item 2.02 filings. Amendments are listed but do not automatically replace the original report's facts.
10-Q · Period ended 2026-07-05 →Accession 0000031791-26-000027
8-K · Results of operations disclosure →Accession 0000031791-26-000022
10-Q · Period ended 2026-04-05 →Accession 0000031791-26-000019
8-K · Results of operations disclosure →Accession 0000031791-26-000016
10-K · Period ended 2025-12-28 →Accession 0000031791-26-000012
8-K · Results of operations disclosure →Accession 0000031791-26-000007
8-K · Results of operations disclosure →Accession 0000031791-26-000003
10-Q · Period ended 2025-09-28 →Accession 0000031791-25-000037
8-K · Results of operations disclosure →Accession 0000031791-25-000032
10-Q · Period ended 2025-06-29 →Accession 0000031791-25-000026
8-K · Results of operations disclosure →Accession 0000031791-25-000022
10-Q · Period ended 2025-03-30 →Accession 0000031791-25-000015
8-K · Results of operations disclosure →Accession 0000031791-25-000012
10-K · Period ended 2024-12-29 →Accession 0000031791-25-000009
8-K · Results of operations disclosure →Accession 0000031791-25-000006
8-K · Results of operations disclosure →Accession 0000031791-25-000003
10-Q · Period ended 2024-09-29 →Accession 0000031791-24-000028
8-K · Results of operations disclosure →Accession 0000031791-24-000026
10-Q · Period ended 2024-06-30 →Accession 0000031791-24-000021
8-K · Results of operations disclosure →Accession 0000031791-24-000018
10-Q · Period ended 2024-03-31 →Accession 0000031791-24-000014
8-K · Results of operations disclosure →Accession 0001628280-24-018795
10-K · Period ended 2023-12-31 →Accession 0000031791-24-000004
8-K · Results of operations disclosure →Accession 0001157523-24-000146
Read with context.
These are automatically extracted filing facts, not a complete financial review. Different companies and report types may use different reporting periods and accounting definitions. Missing values are not zero. No stock prices, earnings forecasts, or buy/sell ratings are provided.
All SEC filings for this company · Sources, coverage, and methodology
For education and research only. Not investment advice. Verify original filings before making decisions.